$FLGT
Fulgent Genetics, Inc.

2019 Q2 Form 10-Q Financial Statement

#000156459019031337 Filed on August 12, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2 2017 Q4
Revenue $8.424M $5.400M $4.281M
YoY Change 56.0% 16.38% -26.87%
Cost Of Revenue $3.620M $2.544M $2.545M
YoY Change 42.3% 35.39% 36.61%
Gross Profit $4.804M $2.856M $1.736M
YoY Change 68.21% 3.44% -56.5%
Gross Profit Margin 57.03% 52.89% 40.55%
Selling, General & Admin $2.935M $2.645M $2.482M
YoY Change 10.96% 32.85% 29.68%
% of Gross Profit 61.09% 92.61% 142.97%
Research & Development $1.574M $1.212M $1.324M
YoY Change 29.87% 31.74% 61.86%
% of Gross Profit 32.76% 42.44% 76.27%
Depreciation & Amortization $511.0K $562.0K $400.0K
YoY Change -9.07% 38.77% 0.0%
% of Gross Profit 10.64% 19.68% 23.04%
Operating Expenses $4.509M $3.857M $3.806M
YoY Change 16.9% 32.5% 39.31%
Operating Profit $295.0K -$1.001M -$2.070M
YoY Change -129.47% 567.33% -264.42%
Interest Expense $200.0K $100.0K $100.0K
YoY Change 100.0% 0.0% 0.0%
% of Operating Profit 67.8%
Other Income/Expense, Net
YoY Change
Pretax Income $487.0K -$903.0K -$1.973M
YoY Change -153.93% 2910.0% -249.92%
Income Tax $7.000K -$100.0K -$596.0K
% Of Pretax Income 1.44%
Net Earnings $331.0K -$1.049M -$1.624M
YoY Change -131.55% 4096.0% -299.75%
Net Earnings / Revenue 3.93% -19.43% -37.94%
Basic Earnings Per Share -$0.06 -$0.09
Diluted Earnings Per Share $15.79K -$0.06 -$0.09
COMMON SHARES
Basic Shares Outstanding 18.34M 17.92M
Diluted Shares Outstanding 19.02M 17.92M

Balance Sheet

Concept 2019 Q2 2018 Q2 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.99M $30.60M $26.48M
YoY Change -11.81% 5.88% 26.72%
Cash & Equivalents $9.165M $3.654M $6.490M
Short-Term Investments $17.82M $26.90M $19.99M
Other Short-Term Assets $2.267M $1.000M $2.438M
YoY Change 126.7% 11.11% 169.09%
Inventory
Prepaid Expenses $1.024M $568.0K $624.0K
Receivables $5.543M $5.100M $4.005M
Other Receivables $33.00K $42.00K $66.00K
Total Short-Term Assets $34.80M $38.20M $32.93M
YoY Change -8.91% 10.09% 25.97%
LONG-TERM ASSETS
Property, Plant & Equipment $5.937M $7.300M $7.272M
YoY Change -18.67% 8.96% 16.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.084M $9.400M $1.937M
YoY Change -88.47% -9052.38%
Other Assets $167.0K $600.0K $39.00K
YoY Change -72.17% 500.0% 129.41%
Total Long-Term Assets $21.64M $17.30M $24.26M
YoY Change 25.09% -28.23% -23.96%
TOTAL ASSETS
Total Short-Term Assets $34.80M $38.20M $32.93M
Total Long-Term Assets $21.64M $17.30M $24.26M
Total Assets $56.44M $55.50M $57.18M
YoY Change 1.69% -5.62% -1.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.175M $1.800M $2.089M
YoY Change -34.72% -1.1% -24.2%
Accrued Expenses $1.333M $1.200M $911.0K
YoY Change 11.08% 33.04% 108.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.909M $3.000M $3.000M
YoY Change -3.03% 7.14% -9.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.400M $0.00 $6.000K
YoY Change 200.0%
Total Long-Term Liabilities $2.400M $0.00 $6.000K
YoY Change 200.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.909M $3.000M $3.000M
Total Long-Term Liabilities $2.400M $0.00 $6.000K
Total Liabilities $5.294M $3.000M $3.006M
YoY Change 76.47% -3.23% -15.59%
SHAREHOLDERS EQUITY
Retained Earnings -$64.60M -$57.66M
YoY Change 4.55%
Common Stock $115.5M $111.9M
YoY Change 1.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $51.14M $52.56M $54.18M
YoY Change
Total Liabilities & Shareholders Equity $56.44M $55.50M $57.18M
YoY Change 1.69% -5.61% -1.47%

Cashflow Statement

Concept 2019 Q2 2018 Q2 2017 Q4
OPERATING ACTIVITIES
Net Income $331.0K -$1.049M -$1.624M
YoY Change -131.55% 4096.0% -299.75%
Depreciation, Depletion And Amortization $511.0K $562.0K $400.0K
YoY Change -9.07% 38.77% 0.0%
Cash From Operating Activities $600.0K $0.00 -$1.300M
YoY Change -100.0% -208.33%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K -$100.0K -$1.100M
YoY Change 400.0% -92.86% 175.0%
Acquisitions
YoY Change
Other Investing Activities $3.700M -$1.500M -$700.0K
YoY Change -346.67% -126.79% -98.21%
Cash From Investing Activities $3.200M -$1.600M -$1.700M
YoY Change -300.0% -138.1% -95.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities 600.0K 0.000 -1.300M
Cash From Investing Activities 3.200M -1.600M -1.700M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 3.800M -1.600M -3.000M
YoY Change -337.5% -133.33% 900.0%
FREE CASH FLOW
Cash From Operating Activities $600.0K $0.00 -$1.300M
Capital Expenditures -$500.0K -$100.0K -$1.100M
Free Cash Flow $1.100M $100.0K -$200.0K
YoY Change 1000.0% -95.0% -112.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9165000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6736000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3160000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4509000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
17820000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5543000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5948000
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2267000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2561000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24298000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
115532000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114203000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
203000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
34795000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
39543000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
11697000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
6386000
CY2019Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1084000
CY2018Q4 us-gaap Equity Method Investments
EquityMethodInvestments
1512000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5937000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6446000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2756000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
17000
CY2019Q2 us-gaap Assets
Assets
56436000
CY2018Q4 us-gaap Assets
Assets
53904000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1175000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1313000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1333000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1425000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
401000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2909000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2738000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2385000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14000
CY2019Q2 us-gaap Liabilities
Liabilities
5294000
CY2018Q4 us-gaap Liabilities
Liabilities
2752000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
2000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64595000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63018000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
51142000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
51152000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56436000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53904000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
585000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
590000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18172000
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18393000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18172000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
487000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-903000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8424000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5400000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13794000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10053000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
3620000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
2544000
us-gaap Cost Of Revenue
CostOfRevenue
6588000
us-gaap Cost Of Revenue
CostOfRevenue
5316000
CY2019Q2 us-gaap Gross Profit
GrossProfit
4804000
CY2018Q2 us-gaap Gross Profit
GrossProfit
2856000
us-gaap Gross Profit
GrossProfit
7206000
us-gaap Gross Profit
GrossProfit
4737000
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1574000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1212000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2998000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2670000
CY2019Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1304000
CY2018Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1279000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2576000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2409000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1631000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1366000
us-gaap Operating Expenses
OperatingExpenses
7932000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1001000
us-gaap Operating Income Loss
OperatingIncomeLoss
-1528000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3195000
CY2019Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
192000
CY2018Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
98000
us-gaap Interest And Other Income
InterestAndOtherIncome
399000
us-gaap Interest And Other Income
InterestAndOtherIncome
193000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1129000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3002000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-534000
CY2019Q2 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
480000
CY2018Q2 flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-803000
flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-1149000
flgt Income Loss Before Equity In Net Income Loss Of Investee
IncomeLossBeforeEquityInNetIncomeLossOfInvestee
-2468000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-149000
CY2018Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-246000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-428000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-491000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000
us-gaap Net Income Loss
NetIncomeLoss
-1577000
us-gaap Net Income Loss
NetIncomeLoss
-2959000
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.06
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.09
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.17
CY2018Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.06
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.09
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.17
CY2018Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-43000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-21000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17919000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18286000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17891000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17919000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18286000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17891000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-14000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
122000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
237000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-17000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
439000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1044000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1339000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2997000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
49961000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
108000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
53025000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
573000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
52561000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
238000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
54178000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1118000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
us-gaap Cumulative Effect On Retained Earnings Before Tax1
CumulativeEffectOnRetainedEarningsBeforeTax1
327000
us-gaap Cumulative Effect On Retained Earnings Tax1
CumulativeEffectOnRetainedEarningsTax1
74000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000
us-gaap Profit Loss
ProfitLoss
-1577000
us-gaap Profit Loss
ProfitLoss
-2959000
us-gaap Share Based Compensation
ShareBasedCompensation
1320000
us-gaap Share Based Compensation
ShareBasedCompensation
1118000
us-gaap Depreciation
Depreciation
1046000
us-gaap Depreciation
Depreciation
1078000
flgt Noncash Lease Expense
NoncashLeaseExpense
201000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-11000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-55000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
44000
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
160000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
230000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-535000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-38000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-38000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-368000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
990000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-183000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-22000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-124000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1344000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1288000
flgt Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-188000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1730000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1348000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
633000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1152000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
10178000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11470000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11500000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
11656000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
510000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
689000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2836000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1476000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-21000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2429000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6490000
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3654000
us-gaap Income Taxes Paid
IncomeTaxesPaid
20000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1011000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting periods. These estimates, judgments and assumptions are based on historical data and experience available at the date of the accompanying condensed consolidated financial statements, as well as various other factors management believes to be reasonable under the circumstances. Actual results could differ from these estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an on-going basis, management evaluates its estimates, primarily those related to: (i) revenue recognition criteria, (ii) accounts receivable and allowances for doubtful accounts, (iii) the useful lives of fixed assets, (iv) estimates of tax liabilities and (v) equity method investments.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Customers</p> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In certain periods, a small number of customers has accounted for a significant portion of the Company&#8217;s revenue. <font style="Background-color:#FFFFFF;">In the </font><font style="color:#000000;">three months ended June 30, 2019</font><font style="Background-color:#FFFFFF;">, after aggregating customers that are under common control or are affiliates, </font><font style="color:#000000;">two</font><font style="Background-color:#FFFFFF;"> customers contributed 32% and 15%, respectively, of our revenue for the period. In the six months ended June 30, 2019, after aggregating customers that are under common control or are affiliates, two customers contributed 27% and 10%, respectively, of our revenue for the period. </font>In the <font style="color:#000000;">three and six months ended June 30, 2018</font>, after <font style="Background-color:#FFFFFF;">aggregating customers that are under common control or are affiliates, one customer contributed 13% of our revenue.</font></p>
us-gaap Revenue Practical Expedient Remaining Performance Obligation
RevenuePracticalExpedientRemainingPerformanceObligation
true
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3000000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3000000
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
29371000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
159000
CY2019Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
29517000
CY2019Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
3722000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
30776000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
104000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
30684000
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2692000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
13000
CY2018 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
104000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
0
CY2019Q2 flgt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2019Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
13000
CY2019Q2 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12874000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12332000
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6937000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5886000
CY2019Q2 us-gaap Depreciation
Depreciation
511000
CY2018Q2 us-gaap Depreciation
Depreciation
562000
CY2019Q2 flgt Reagents Current
ReagentsCurrent
405000
CY2018Q4 flgt Reagents Current
ReagentsCurrent
314000
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1024000
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
706000
CY2019Q2 us-gaap Prepaid Taxes
PrepaidTaxes
609000
CY2018Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1251000
CY2019Q2 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
196000
CY2018Q4 flgt Marketable Securities Interest Receivable Current
MarketableSecuritiesInterestReceivableCurrent
220000
CY2019Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
33000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
flgt Operating Leases Term Of Expiration
OperatingLeasesTermOfExpiration
2023-08
CY2019Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
133000
CY2018Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
70000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y1M6D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0625
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
281000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
559000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
550000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
558000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
567000
CY2019Q2 flgt Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
330000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.02
CY2018Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.11
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.18
CY2019Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2018Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.30
CY2018Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
119000
us-gaap Operating Lease Expense
OperatingLeaseExpense
266000
us-gaap Operating Lease Expense
OperatingLeaseExpense
228000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
384000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2600000
us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
0
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
146000
us-gaap Operating Lease Cost
OperatingLeaseCost
292000
CY2019Q2 flgt Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
116000
flgt Cash Paid For Amounts Included In Measurement Of Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities
278000
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
101000
us-gaap Operating Lease Payments
OperatingLeasePayments
201000
CY2019Q2 flgt Lessee Operating Lease Liability Payments Due Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueThereafter
532000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3377000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
591000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2786000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
560000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
559000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
550000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
558000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
567000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
862000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3656000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
737000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
573000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1320000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1118000
CY2019Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01

Files In Submission

Name View Source Status
0001564590-19-031337-index-headers.html Edgar Link pending
0001564590-19-031337-index.html Edgar Link pending
0001564590-19-031337.txt Edgar Link pending
0001564590-19-031337-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
flgt-10q_20190630.htm Edgar Link pending
flgt-20190630.xml Edgar Link completed
flgt-20190630.xsd Edgar Link pending
flgt-20190630_cal.xml Edgar Link unprocessable
flgt-20190630_def.xml Edgar Link unprocessable
flgt-20190630_lab.xml Edgar Link unprocessable
flgt-20190630_pre.xml Edgar Link unprocessable
flgt-ex101_266.htm Edgar Link pending
flgt-ex311_7.htm Edgar Link pending
flgt-ex312_8.htm Edgar Link pending
flgt-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending